Absi Corp (NASDAQ:ABSI), Recursion Pharma (NASDAQ:RXRX), Schrodinger (NASDAQ:SDGR), and Certara (NASDAQ:CERT) are ...

We came across a bullish thesis on AbCellera Biologics Inc. (ABCL) on Twitter by Jack Prescott. In this article, we will ...

AbbVie (NYSE:ABBV) and AbCellera (NASDAQ:ABCL) have expanded their collaboration to include the discovery of T-cell engagers for the treatment of cancer. Under the deal, AbCellera (NASDAQ ...

As the U.S. stock market continues to rally following President Trump's return to office, investors are closely watching the impact of new policies on various sectors. In this context, penny ...

AbCellera Biologics Inc (ABCL) stock saw a modest uptick, ending the day at $3 which represents a slight increase of $0.08 or 2.74% from the prior close of $2.92. The stock opened at $2.98 and touched ...

AbCellera is expanding its collaboration with pharmaceutical company AbbVie to include the discovery of T-cell engagers in oncology. The new agreement will see the Canadian developer of antibody ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

AbCellera (Nasdaq: ABCL) announced today that it has expanded its existing collaboration with AbbVie Inc. (NYSE: ABBV) to include the discovery of T-cell engagers (TCE) in oncology. The expansion ...

We came across a bullish thesis on AbCellera Biologics Inc. (ABCL) on Twitter by Jack Prescott. In this article, we will summarize the bulls’ thesis on ABCL. AbCellera Biologics Inc. (ABCL ...

VANCOUVER, British Columbia, January 13, 2025--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) announced today that it has expanded ...